Diversified Trust Co bought a new stake in Steris Corp. (NYSE:STE) during the second quarter, Holdings Channel reports. The institutional investor bought 4,650 shares of the company’s stock, valued at approximately $320,000.
Other large investors also recently bought and sold shares of the company. State Street Corp increased its stake in Steris Corp. by 0.3% in the first quarter. State Street Corp now owns 2,687,145 shares of the company’s stock valued at $190,922,000 after buying an additional 8,408 shares in the last quarter. BlackRock Institutional Trust Company N.A. increased its stake in shares of Steris Corp. by 2.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,426,099 shares of the company’s stock worth $172,374,000 after buying an additional 54,810 shares during the period. Fisher Asset Management LLC increased its stake in shares of Steris Corp. by 0.5% in the second quarter. Fisher Asset Management LLC now owns 1,622,504 shares of the company’s stock worth $112,099,000 after buying an additional 8,584 shares during the period. Wellington Management Group LLP increased its stake in shares of Steris Corp. by 1.0% in the first quarter. Wellington Management Group LLP now owns 1,390,731 shares of the company’s stock worth $98,810,000 after buying an additional 13,927 shares during the period. Finally, Hermes Investment Management Ltd. increased its stake in shares of Steris Corp. by 6.3% in the second quarter. Hermes Investment Management Ltd. now owns 848,936 shares of the company’s stock worth $58,364,000 after buying an additional 49,956 shares during the period. Hedge funds and other institutional investors own 91.58% of the company’s stock.
Steris Corp. (NYSE:STE) traded down 0.72% on Thursday, reaching $72.63. The company had a trading volume of 530,543 shares. The stock’s 50 day moving average price is $71.29 and its 200-day moving average price is $70.20. The stock has a market capitalization of $6.26 billion, a PE ratio of 41.72 and a beta of 1.16. Steris Corp. has a 12-month low of $61.38 and a 12-month high of $78.77.
Steris Corp. (NYSE:STE) last posted its earnings results on Tuesday, August 9th. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. Steris Corp. had a net margin of 5.52% and a return on equity of 10.72%. The business earned $638.40 million during the quarter, compared to the consensus estimate of $639.04 million. During the same quarter in the previous year, the firm posted $0.62 EPS. The firm’s revenue was up 45.1% on a year-over-year basis. Equities analysts expect that Steris Corp. will post $3.90 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 27th. Shareholders of record on Tuesday, August 30th were given a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date of this dividend was Friday, August 26th. This is an increase from Steris Corp.’s previous quarterly dividend of $0.25. Steris Corp.’s payout ratio is 68.71%.
STE has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Steris Corp. from a “sell” rating to a “hold” rating in a research report on Friday, August 26th. Northcoast Research upgraded Steris Corp. from a “neutral” rating to a “buy” rating in a research report on Friday, June 3rd.
In other news, CEO Walter M. Rosebrough, Jr. sold 15,000 shares of the business’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $71.08, for a total transaction of $1,066,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard Martin Steeves sold 204,778 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $71.19, for a total transaction of $14,578,145.82. Following the sale, the director now directly owns 165,434 shares of the company’s stock, valued at approximately $11,777,246.46. The disclosure for this sale can be found here. 2.52% of the stock is currently owned by company insiders.
Steris Corp. Company Profile
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.